PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2003) 27: 11-13. doi: 10.1192/pb.27.1.11
© 2003 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Connolly, C.
Right arrow Articles by Bullock, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Connolly, C.
Right arrow Articles by Bullock, R.
Psychiatric Bulletin (2003) 27: 11-13
© 2003 The Royal College of Psychiatrists

Treatment of patients with Alzheimer's disease: a national survey following release of the NICE guidance

Claire Connolly, Research Assistant and Roger Bullock, Clinical Director

Kingshill Research Centre, Victoria Hospital, Okus Road, Swindon SN1 4HZ

Declaration of interest

The pharmaceutical companies Janssen-Cilag and Shire met the cost of the administration of this project.

AIMS AND METHOD

The National Institute for Clinical Excellence (NICE) has issued guidance regarding the treatment of Alzheimer's disease. A postal survey of old age psychiatrists, geriatricians and neurologists was conducted to establish working practice pre-NICE and investigate expectations about the effect of this guidance.

RESULTS

The overall response rate was 26.3%. Old age psychiatrists prescribe the majority of drugs for the treatment of Alzheimer's disease. There was variation in the annual expenditure on such treatment. The main reason for non-prescription was a lack of funding. Over 80% of doctors thought that patients with mild disease should now be targeted for treatment.

CLINICAL IMPLICATIONS

In order to implement the guidance it will be necessary to address the issue of funding and have clear role allocation between local services.




This article has been cited by other articles:


Home page
Age AgeingHome page
J. Cerejeira and E. B. Mukaetova-Ladinska
Treating dementia: will the NICE guidance 2006 change our clinical practice?
Age Ageing, November 1, 2007; 36(6): 605 - 606.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2003 The Royal College of Psychiatrists.